Other
Chronic Pelvic Pain
0
Pipeline Programs↗
6
Active Trials↗
0
Companies Involved↗
Chronic Pelvic Pain is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
17
clinical trials
Completed5 · 29%
Unknown status3 · 18%
Not yet recruiting3 · 18%
Terminated3 · 18%
Recruiting2 · 12%
Active, not recruiting1 · 6%
Clinical Trials
Trial Activity
17 trials
A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain
Active, not recruiting·—·Phase 3·NCT05658874·26 enrolled
Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain
Completed·—·N/A·NCT02369068·21 enrolled
Effect of Nicotine on Chronic Pelvic Pain
Completed·—·Phase 4·NCT00440505·20 enrolled
Efficacy of Gralise® for Chronic Pelvic Pain
Terminated·—·Phase 4·NCT01678911·11 enrolled
Oral Gabapentin in Management of Chronic Pelvic Pain in Females: A Randomised Placebo-controlled Study.
Unknown status·—·Phase 3·NCT02918760·64 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)